BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM

Phase 2positiveBMS-986393Positive

AI Analysis

Summary

BMS reported positive top-line results from the Phase II QUINTESSENTIAL trial of BMS-986393 in adults with quadruple-class exposed relapsed/refractory multiple myeloma.

Clinical Trial Data

Phase

Phase II

Primary Endpoint

Met

Outcome Details

Positive top-line results from Phase II QUINTESSENTIAL trial in adults with quadruple-class exposed r/r MM

Importance:7/10

Sentiment:

0.80

Phase 2 datamultiple myelomaBMS-986393QUINTESSENTIAL trialpositive results

Related Companies

$BMY

Read the original article

Published by Clinical Trials Arena on September 9, 2026 8:57 AM

Read Original